# Phase 2 gastrointestinal cancer trials recruiting: 20 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials in phase 2 for gastrointestinal cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 gastrointestinal cancer trials: 20 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/gastrointestinal-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 20
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 29, 2026 | NCT07848243 | Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes | Peking University Cancer Hospital & Institute | Phase 2 | Recruiting | Lung Cancer (NSCLC), Cervical Squamous Cell Cancer, Melanoma (Skin Cancer), Breast Cancer, Gastrointestinal Cancers | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07848243) |
| September 28, 2026 | NCT07843641 | A Legacy Study in Participants With Gastrointestinal Stromal Tumors (GIST) | GlaxoSmithKline | Phase 2 | Not yet recruiting | Gastrointestinal Neoplasms | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07843641) |
| August 28, 2026 | NCT07793253 | Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 | Not yet recruiting | Biliary Tract Cancers, Intrahepatic Cholangiocarcinoma (Icc), Extrahepatic Cholangiocarcinoma, Gallbladder Carcinoma... | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793253) |
| July 23, 2026 | NCT07723729 | Butyrate Yogurt for Cancer Constipation | Tianjin Medical University Cancer Institute and Hospital | Phase 2 | Not yet recruiting | Constipation, Gastrointestinal Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07723729) |
| July 8, 2026 | NCT07689201 | A Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib | GlaxoSmithKline | Phase 2 | Recruiting | Gastrointestinal Neoplasms | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07689201) |
| May 14, 2026 | NCT07586813 | Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid... | Peking University People's Hospital | Phase 2 | Recruiting | Persistent Isolated Chemotherapy-Induced Thrombocytopenia, Chemotherapy-Induced Thrombocytopenia, Gastrointestinal... | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07586813) |
| April 20, 2026 | NCT07539311 | Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers | Genmab | Phase 2 | Recruiting | Gastrointestinal Cancers | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07539311) |
| August 12, 2025 | NCT07118566 | Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases | China Medical University, China | Phase 2 | Not yet recruiting | Gastrointestinal Cancer, Immunotherapy, Liver Metastasis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07118566) |
| June 26, 2025 | NCT07039526 | Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in... | Sponsor not shown (see the record) | Phase 2 | Recruiting | Esophageal Cancer, Gastrointestinal Cancers, Gynecologic Cancers | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07039526) |
| March 4, 2025 | NCT06855524 | Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer | Mayo Clinic | Phase 2 | Recruiting | Malignant Digestive System Neoplasm, Malignant Female Reproductive System Neoplasm, Breast Carcinoma, Lung Carcinoma... | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06855524) |
| January 7, 2025 | NCT06760819 | A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a... | Bayer | Phase 2 | Recruiting | Advanced Solid Tumors, HER2 Mutation | 111 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06760819) |
| August 20, 2024 | NCT06562348 | The ctDNA-RECIST Trial Part One | Sponsor not shown (see the record) | Phase 2 | Recruiting | Gastrointestinal Neoplasm | 167 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06562348) |
| June 26, 2024 | NCT06475352 | Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme | UNICANCER | Phase 2 | Recruiting | Digestive Cancer, Colorectal Cancer | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06475352) |
| March 29, 2023 | NCT05789485 | A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers | Memorial Sloan Kettering Cancer Center | Phase 2 | Recruiting | Gastrointestinal Cancer | 216 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05789485) |
| December 15, 2022 | NCT05651672 | Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations | Tianjin Medical University Cancer Institute and Hospital | Phase 2 | Recruiting | Gastrointestinal Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05651672) |
| August 9, 2022 | NCT05494060 | XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction... | The First Affiliated Hospital with Nanjing Medical University | Phase 2 | Recruiting | Carcinoma, Gastrointestinal Diseases, Stomach Cancer, Gastroesophageal-junction Cancer, Digestive System Diseases... | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05494060) |
| February 23, 2022 | NCT05252078 | Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients | Jiangxi Provincial Cancer Hospital | Phase 2 | Recruiting | Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Esophageal Diseases, Gastrointestinal Neoplasms... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05252078) |
| May 25, 2021 | NCT04899908 | Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases | Brigham and Women's Hospital | Phase 2 | Recruiting | Brain Cancer, Brain Metastases, Melanoma, Lung Cancer, Breast Cancer, HER2-positive Breast Cancer, Colorectal Cancer... | 134 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04899908) |
| February 13, 2020 | NCT04268121 | Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas | GERCOR - Multidisciplinary Oncology Cooperative Group | Phase 2 | Recruiting | Neuroendocrine Carcinoma, Digestive Cancer | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04268121) |
| January 11, 2019 | NCT03800693 | 2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers | Emory University | Phase 2 | Recruiting | Malignant Digestive System Neoplasm | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03800693) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 2 |
| Tianjin Medical University Cancer Institute and Hospital | 2 |
| Mayo Clinic | 1 |
| Brigham and Women's Hospital | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Emory University | 1 |
| UNICANCER | 1 |
| China Medical University, China | 1 |
| [Genmab](https://specstream.ai/data/clinical-trials/company/genmab) | 1 |
| GERCOR - Multidisciplinary Oncology Cooperative Group | 1 |
| Jiangxi Provincial Cancer Hospital | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| Peking University People's Hospital | 1 |
| [Bayer](https://specstream.ai/data/clinical-trials/company/bayer) | 1 |
| Peking University Cancer Hospital & Institute | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 8 |
| China | 6 |
| France | 4 |
| Japan | 3 |
| Denmark | 2 |
| Australia | 2 |
| South Korea | 2 |
| Spain | 2 |
| Belgium | 1 |
| Germany | 1 |
| Netherlands | 1 |
| Taiwan | 1 |
| United Kingdom | 1 |
| Canada | 1 |
| Italy | 1 |
| Switzerland | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Farm equipment suppliers in the United States](https://specstream.ai/data/businesses/farm-equipment-suppliers/united-states)
- [Banks in the United States](https://specstream.ai/data/businesses/banks/united-states)
- [Steakhouses in the United States](https://specstream.ai/data/businesses/steakhouses/united-states)
- [Metal suppliers in the United States](https://specstream.ai/data/businesses/metal-suppliers/united-states)
- [Farm equipment repair companies in the United States](https://specstream.ai/data/businesses/farm-equipment-repair-companies/united-states)
- [Bankruptcy law firms in the United States](https://specstream.ai/data/businesses/bankruptcy-law-firms/united-states)
